Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$-117.86 Mln
EBITDA
$-81.87 Mln
Net Profit
$-80.45 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biofrontera Inc. Warrants (BFRIW)
| -72.2 | 0.0 | -5.3 | -83.2 | -26.2 | -- | -- |
|
BSE Sensex*
| -9.8 | -2.2 | 2.9 | -4.9 | 5.3 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Biofrontera Inc. Warrants (BFRIW)
| 48.3 | 498.1 | -95.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Biofrontera Inc. Warrants (BFRIW)
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED... Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Read more
-
CEO, President & Executive Chairman
Dr. Hermann Luebbert Ph.D.
-
CEO, President & Executive Chairman
Dr. Hermann Luebbert Ph.D.
-
Headquarters
Woburn, MA
-
Website
FAQs for Biofrontera Inc. Warrants (BFRIW)
What is the current share price of Biofrontera Inc Warrants (BFRIW) Today?
The share price of Biofrontera Inc Warrants (BFRIW) is $0.03 (NASDAQ) as of 28-Aug-2026 15:40 EDT. Biofrontera Inc Warrants (BFRIW) has given a return of -26.2% in the last 3 years.
What is the current PB & PE ratio of Biofrontera Inc Warrants (BFRIW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.10 |
0.10 |
2024 |
-0.02 |
0.08 |
2023 |
0.00 |
0.00 |
2022 |
-0.42 |
0.01 |
2021 |
-1.63 |
5.43 |
What is the 52 Week High and Low of Biofrontera Inc Warrants (BFRIW)?
The 52-week high and low of Biofrontera Inc Warrants (BFRIW) are Rs 0.15 and Rs 0.02 as of 02-Sep-2026.
What is the market cap of Biofrontera Inc Warrants (BFRIW)?
Biofrontera Inc Warrants (BFRIW) has a market capitalisation of -- as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biofrontera Inc Warrants (BFRIW)?
Before investing in Biofrontera Inc Warrants (BFRIW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.